Finance

Research company announces public offering of common stock

Published in Biotech Business Week, February 21st, 2005

Nuvelo, Inc., (NASDAQ:NUVO) announced plans to offer 7,000,000 shares of its common stock in an underwritten public offering.

The offering will be made pursuant to the company's effective shelf registration statement previously filed with the U.S. Securities and Exchange Commission. The underwriters will have an option to purchase up to an additional 1,050,000 shares to cover over-allotments.

UBS Securities LLC is acting as the sole book-running manager in this offering with Deutsche Bank Securities Inc. acting as a colead manager and CIBC World Markets Corp. and Needham & Company, Inc. acting as comanagers.

Nuvelo, Inc. is...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2005-02-21)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry